Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | Share of resistant isolates |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Source
Release date
July 2026
More information
Region
Worldwide, Europe
Survey time period
2022
Supplementary notes
Acinetobacter species are bacteria causing healthcare-associated infections, such as pneumonia associated with the use of a ventilator, central line-associated bloodstream infections, and postoperative wound infections.
Carbapenem antibiotics include imipenem and meropenem.
Release date represents the date figures were accessed.
Citation formats
